In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Janssen Pharmaceuticals Inc.

www.janssenpharmaceuticalsinc.com

Latest From Janssen Pharmaceuticals Inc.

Moderna, Pfizer Protocols May Make COVID Vaccine Candidates Hard to Compare

While Operation Warp Speed is trying to harmonize coronavirus study designs, Pfizer’s go-it-alone approach may make its vaccine hard to compare to others.

Coronavirus COVID-19 Vaccines

EMA Wants Panexcell-Tested Generics Suspended; Spares Yondelis

The European Medicines Agency says that available evidence from a discontinued study does not call into question PharmaMar/Janssen’s Yondelis in its currently authorized uses. But in a separate recommendation it says that bioequivalence studies on generic drugs conducted by CRO Panexcell might be flawed.

Europe Drug Safety
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register